Enzymatic assay of homocysteine on microtiter plates or a TECAN analyzer using crude lysate containing recombinant methionine γ-lyase

Annals of Clinical and Laboratory Science

Volumn 35, Issue 2, 2005, Pages 155-160

  Chan, Err Cheng ^a   Chang, Pi Yueh ^b   Wu, Tsu Lan ^a   Wu, James T ^c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c ARUP LABORATORIES   (United States)

Author keywords

Enzymatic assay; Homocysteine; Methionine lyase; Microtiter plate; TECAN analyzer

Indexed keywords

HOMOCYSTEINE; METHIONINE GAMMA LYASE;

ACCURACY; ADULT; AGED; ARTICLE; AUTOANALYZER; BLOOD LEVEL; BLOOD SAMPLING; CALIBRATION; CENTRIFUGATION; CHINESE; CONTROLLED STUDY; ENZYME ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MICROTITER PLATE ASSAY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SERUM; SEX RATIO; VEIN PUNCTURE;

ADULT; AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARBON-SULFUR LYASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESCHERICHIA COLI; FEMALE; HOMOCYSTEINE; HUMANS; INDICATORS AND REAGENTS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; SEX FACTORS;

EID: 18744373039     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Malinow MR. Plasma homocyst(e)ine and arterial occlusive diseases: a mini-review. Clin Chem 1995;41:173-176.
2. McCully KS: Homocysteine and vascular disease. Nature Med 1996;2:386-389.
3. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I, Fiskerstrand T. Hyperhomocysteinemia: an independent risk factor for vascular disease. NEJM 1991;324:1149-1155.
4. (12) and folate. Clin Chem 2000;46:1277-1283.
5. Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, Johnston C, Engbaek f, Schneede J, McPartlin C, Scott JM. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 2004;50:3-32.
6. Wu LL, Wu JT. Hyperhomocysteinemia is a risk factor for cardiovascular disease and a marker for cancer risk: biochemical bases. Clin Chim Acta 2002;322:21-28.
7. Sun C-F, Haven TR, Wu T-L, Tsao K-C, Wu JT. Serum homocysteine increases with the rapid proliferation rate of tumor cells and decline upon cell death: a potential new tumor marker. Clin Chim Acta 2002;321:55-62
8. Wu, LL, Wu J, Hunt SC, James BC, Vincent GM, Willianms RR, Hopkins PN. Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clin Chem 1994;40:552-561.
9. Nexo E, Engbaer F, Ueland PM, Westby C, O'Gorman P, Johnston C, Kase BF, Guttormsen AB, Alfheim I, McPartlin J, Smith D, Moller J, Rasmussen K, Clarke R, Scott JM, Refsum H. Evaluation of novel assays in clinical chemistry: quantification of plasma total homocysteine. Clin Chem 2000;46:1150-1156.
10. Tan Y, Tang L, Sun X, Zhang N, Han Q, Xu M, Baranov E, Tan XZ, Tan XY, Rashidi B, An Z, Perry AW, Hoffman RM. Total-homocysteine enzymatic assay. Clin Chem 2000;46,1686-1688.
11. Matsuyama N, Yamaguchi M, Toyosato M, Takayama M Kizuno K. New enzymatic colorimetric assay for total homocysteine. Clin Chem 2001;47:2155-2157.
12. Han Q, Lenz M, Tan Y, Xu M, Sun X, Tan XZ, Tan XY, Tang L, Miljkovic D, Hoffman RM. High expression, purification and properties of recombinant homocysteine, α,γ-lyase. Protein Expr Purif 1998;14:267-274.
13. Uchida T, Yamashita S. Molecular cloning, characterization, and expression in Escherichia coli of a cDNA encoding mammalian choline kinase. J Biol Chem 1992:267:10156-10162.
14. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989;114:473-500.
15. Moller J, Rasmussen K. Homocysteine in plasma: Stabilization of blood samples with fluoride. Clin Chem 1995;41,758-759.
16. Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: Automated determination and sample stability. Clin Chem 1993:39,263-271.